Cat.#: ACPP-1330
| Despition | PAX2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1050 | Recombinant Human LIF Protein (Fc Tag) (AC1050) | 50 µg | inquiry |
| ACPP-1830 | Human SDC1 Protein (AC1830) | 5 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
| ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
| ACPP-1544 | Human GAPDH Protein (AC1544) | 5 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.